University of Manchester
By
University of Manchester
Published: Dec. 15, 2021, 4:52 p.m.·
Tags:
Drug-resistant TB,
Treatment
TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight difficult-to-treat infections. TaBriX’s initial focus is on the treatment of drug-resistant TB.
Read More →
By
University of Manchester
Published: Dec. 8, 2021, 3:19 p.m.·
Tags:
TB care
A study of tuberculosis patients in six Jakarta hospitals has revealed up to 13 per cent of them had fungal lung infection – or aspergillosis – at the end of their treatment.
Read More →
By
University of Manchester
Published: Sept. 16, 2018, 7:47 p.m.·
Tags:
Medicines,
Scientific research
Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals.
Read More →
Page 1 of 1 · Total posts: 3
1